with lyophilized Canicola or Icterohaemorrhagiae bacterin and showed the serovar specificity of their vaccines as no crossprotection was provided against other serovars. Thus, multivalent vaccines have been prepared incorporating several serovars (Copenhageni, Pomona, Hardjo, Grippotyphosa, Autumnalis and Icterohaemorrhagiae) and satisfactory results have been obtained in guinea pigs and hamsters. 12, 13 Brown et al 14 reported the development of formalininactivated, adjuvant containing bacterin. Calves vaccinated with this preparation developed significant agglutination titres, whereas previous bacterins without adjuvant had generated lower titers. In addition, the vaccinated calves successfully resisted challenge with Leptospira infected guinea pig blood.
www.ijmm.org 16 demonstrated that steers given two of pentavalent vaccines containing serovar Hardjo bovis or Hardjoprajitno, failed to protect against the challenge infection as demonstrated by the shedding of organisms in urine though their MAT titres were higher. The study suggested that the efficacy of a vaccine should not be based on serology alone.
Palit et al 17 reported that a trivalent bovine leptospirosis vaccine against Pomona, Copenhageni and Hardjo was immunogenic and capable of inducing high titres. However, the efficacy of the vaccine remained doubtful as no challenge of pups less than 9 or 10 weeks of age is not recommended. In addition, the vaccine-induced immunity in dogs is often less than six months; repeated vaccination in endemic areas would thus be essential for protection.
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In recent years, vaccines against canine leptospirosis in USA have been prepared using immunogenic subunits from most commonly disease causing serovars, Grippotyphosa and Pomona. This is used in addition to the conventional vaccine using Canicola and Icterohaemorrhagiae. The vaccine induces MAT titres not only against Pomona and Grippotyphosa but also against Autumnalis, leading to misdiagnosis of the disease caused by serovar Autumnalis.
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Live attenuated vaccine studies were conducted. Dhaliwal et al 18 on the other hand reported that the efficacy of a vaccine could best be measured One of the first attenuated live vaccines used in cattle was by observing fertility performance and milk yield.
a Pomona vaccine. 28 The leptospires were attenuated by passage through eggs and the vaccine was used in an Leptospiral bacterins, when introduced into domesticated aborting cattle herd. Results from this field study indicated species, often failed to induce significant levels of that both, live and attenuated vaccines protected cattle and agglutinating antibodies, especially in swine in spite of the reduced the abortion rate. use of adjuvant. 19 Hodges et al 20 21 demonstrated that a than 70,000 rad). Guinea pigs vaccinated with the irradiated single vaccination of swine with a killed leptospirosis vaccine leptospires were capable of producing agglutinating antibodies did not induce MAT titres in 96% of animals after 15 days. and showed protection from death and renal infection. Control After 28 days the titres were 1:100 when a booster was given animals and those receiving formalin-killed, sonically disrupted on day 15-post vaccination. These failures led scientists and acid-heat-extracted water-soluble bacterins, failed to toward evaluating the type of immunoglobulins produced in provide adequate protection from clinical disease. response to antigenic stimulation, as animals were often Contradicting results were reported by Babudieri et al 30 that refractory to infection in the absence of an agglutinating titer. 22 irradiated vaccines were no more effective in preventing either Currently a polyvalent anti-leptospiral vaccine called death or persistent renal infection than chemically inactivated Suileptovac TPCI is available for vaccinating swine. This vaccine. In both studies, the vaccines were serovar-specific. vaccine contains serovars Tarassovi, Canicola, Pomona and Icterohaemorrhagiae. Multivalent vaccines are useful in Stalheim 31 either irradiated or exposed serovar Pomona to covering infections caused by a variety of serovars, however, 60 µg/ ml dihydrostreptomycin and carried out vaccinationthe efficacy of such vaccines against diseases caused by all challenge studies in hamsters and swine. Protection was seen the serovars incorporated in the vaccine is doubtful. There in both groups of animals. However, when vaccinated hamsters are a few reports, which have demonstrated that the were challenged with a non-lethal Pomona serovar, which was vaccinated animals may not develop antibody titres against capable of establishing renal infection, only 60% (6 of 10) were all the serovars incorporated in the vaccine.
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protected from renal infection. Leptospires could not be detected in the kidneys of challenged pigs given the Bramel and Scheidy 24 evaluated the effect of re vaccination on horses and calves with a Pomona bacterin. Results in horses indicated a local swelling at the injection site that persisted for three to four days. One vaccination had no adverse reaction on the horse.
Bivalent bacterins for dogs that contain Canicola and Icterohaemorrhagiae have been in the market since the 1950s. 25 They are prepared from chemically inactivated whole cells, which make them relatively allergenic. Because immunity after vaccination is highly serovar specific, immunized dogs are not protected against other serovars that are common in many areas and that may infect dogs. They may also suppress the immune response in young puppies and thus vaccination experimental vaccines 14 days previously.
In the early 1970s, Fish and Kingscote 32 immunized swine with a live avirulent Pomona vaccine. Upon challenge, only control pigs were infected. Sentinel pigs did not have demonstrable agglutinins whereas the vaccinated pigs had low transient titers. Sera from vaccinated pigs with no titer were capable of passively protecting guinea pigs. Even though the attenuated live vaccines were capable of stimulating higher titers than chemically inactivated leptospiral bacterins, they have not gained wide acceptance or use among veterinary biologic manufacturers. This is probably due to the difficulty of maintaining the viability upon storage as well as the possible reversion to the virulent state in the host animal. 
Acellular Vaccines
From killed bacterins, the focus of Leptospira vaccine research shifted towards defining the primary structural component responsible for protection upon challenge.
In a previous work Anderson and Johnson 33 had noted that the primary target for antibody complement action on the leptospires was in the outer envelope (OE) as evidenced by electron microscopy. Also, the virulent leptospires were more resistant to the action of antibody complement than avirulent, leaving the impression that virulent leptospires possessed some component in the OE that may be associated with virulence. Subsequently, Auran et al 34 removed the OE of
Outer membrane proteins
OMPs as a whole or fractionated, conserved proteins among pathogenic leptospires that can generate cross protection against various serovars has become a major focus of current leptospirosis vaccine research.
Zhang et al
40 prepared an OMP vaccine of 39 kDa molecular weight hydrophobic protein and tested in guinea pigs. The vaccine was found to confer a solid immunity against challenge similar to that observed with a whole cell vaccine. Haake et al 41 examined the immunoprotective capacity of leptospiral transmembrane porin, Omp L1 and Lip41 lipoprotein from Grippotyphosa in hamsters. Hamsters serovar Canicola by solubilizing it in sodium dodecyl sulfate immunized with E. coli membrane expressing both the (SDS) as evidenced by electron microscopy. Once the OE was proteins protected against challenge than vaccinated with removed the protoplasmic cylinder showed loss of intracellular either protein alone, showing synergistic activity of the organization. Immunization of hamsters followed by proteins. A steric hindrance of OmpL1 by LipL41 has been challenging with live organisms after 14 days was protective; proposed for this activity. 42 10 ìg wet weight per animal of either formalinized whole cells demonstrated that OMP from Leptospira spp. was cross (WC) or OE, protected hamsters from death and kidney reactive.
44 identified BMD -3A and BMD -10 genes Bey et al 35 quantitatively compared the immunogenicity in L. interrogans serovar Lai responsible for the expression of lyophilized leptospiral WC and OE vaccines from virulent of antigens important in the generation of immune response and avirulent strains in hamsters, using the criteria of 50% against leptospiral infection. Later, Jiang et al 45 reported the protection from death (PD50D) and kidney protection (PD50K). cloning and expression of two proteins of approximate serovars evaluated were Canicola, molecular mass of 68 and 23 kDa from L. interrogans serovar Icterohaemorrhagiae, Pomona and Grippotyphosa. Results Lai; p68 elicited a strong immune response (MAT titres 1:524, from these studies revealed that the OE and WC from virulent 288) in guinea pigs and generated a titre of 1:262, 144 in rabbits. strains were more immunogenic and protective than the OE The same workers reported that the vaccination of guinea pigs or WC from avirulent strains. Combining the OE from virulent with DNA recombinant plasmid for p68 protected against strains of these four serovars and Hardjo formed a pentavalent virulent L. interrogans serovar Lai. The level of protection in OE vaccine, which had satisfactory immunogenic potency in p68-vaccinated group was 100% as against 75% in DNA hamsters and cattle. 36 vaccinated group. 46 In 1975, Takashima and Yanagawa 37 evaluated the Haake et al 47 demonstrated LipL32 protein as the most immunogenicity of leptospiral OE and the cell wall extracted with SDS. Results of these studies conducted in guinea pigs abundant protein expressed by a conserved gene of supported that the OE was a better immunogen than pathogenic leptospires. This is also called hemolysislyophilized WC, which was better than the cell wall extracted associated protein (Hap-1). OMP L1 in combination with Lip32 with SDS. The protein component of the OE was least had no protective activity in contrast to Lip41 reported earlier. 48 However, studies using gene for vaccination have protective. In addition, it took more immunogen to protect revealed that LipL32 could be a protective immunogen. 48 
Srivastava and Tiwari

infection.
Leptospira guinea pigs from renal infection than death. Siddique and Shah 38 evaluated outer envelope hexavalent (Pomona, Canicola, Hardjo, Icterohaemorrhagiae, Grippotyphosa, Swajizak) vaccine in hamsters. Animals given 10 µg dose developed higher MAT titres and more protection against challenge with Pomona as compared to those given 1 µg dose.
The leptospiral structural component that lies under the OE is the protoplasmic cylinder (PC). Hamsters immunized with various doses of PC from virulent leptospires and challenged 14 days later had similar PD50D values as the OE and WC. 39 Further, dogs immunized with one mg dry weight PC had the greatest number of sensitized lymphocytes, as monitored by blast transformation.
Adenovirus expressed Lip32 protein has been reported to induce significant level of protection in gerbils. 49 Other virulent-associated surface exposed outer membrane proteins include the Lig proteins; Lig A consists only of Ig-like domains, whereas Lig B has an additional unique domain at the C-terminal. 50 Serum samples collected from Leptospira infected dogs or rats showed reactivity with LigA and LigB proteins while serum samples from vaccinated animal showed no reactivity, indicating that these proteins are up-regulated during infection. 51, 52 Further, in a mouse model the Lig proteins elicited protective immunity against challenge with the homologous serovar Manilae as well as the heterologous serovar Icterohaemorrhagiae. While investigating the seroprevalence, care should be protecting mice from death only when given in doses of 50 taken in interpreting the results since no test can differentiate mg/ animal in Freund's incomplete adjuvant. Subsequently, antibodies generated in animals after the vaccination from Adler and Faine 56 found that rabbit antisera against leptospiral those developed after an infection. When more than one LPS protected hamsters from infection only if agglutinins were serovar is chosen to prepare a vaccine, scientific data should concomitantly present, indicating that the lipopolysaccharide be available to exclude any possibility of suppression of may not be an important protective antigen. This was also immune response to any of the serovar(s) added in the supported by the findings that cattle vaccinated with vaccine. Repeated booster immunization may not provide pentavalent vaccine were vulnerable to the infection by sufficient immunity against such serovars. serovar Hardjo despite the presence of high anti-LPS antibody titres. 57 Contrary to this, a recent report indicates that LPS from Development of leptospirosis vaccines is an arduous and L. biflexa serovar Patoc was cross protective to hamsters when time-consuming process. Unlike many other bacteria, challenged with L. interrogans serovar Manilae. 58 spirochetes require fastidious growth conditions. Bulk
Immunization protected hamsters from infection and prevented promotion of organisms may not be achieved satisfactorily. renal carrier stage. Srivastava 59 reported that purified LPS from serovar Pyrogenes was able to generate antibodies in rabbits responsible for lysis of live leptospires. Though this is indicative of the protective efficacy of LPS, more studies are required to arrive at a firm conclusion.
DNA Vaccines
The use of a DNA construct encoding leptospiral proteins is a promising new approach for vaccination against leptospirosis. Several studies using flaB2 gene have been done. [60] [61] [62] The cpG motif, found within the gene and the vector was immunostimulatory and was thought to act as an adjuvant for DNA vaccines.
Use of bio-fermentor may or may not enhance the growth of several serovars, e.g., Canicola.
The potency testing of leptospirosis is a cumbersome process. According to the current United States Standard requirements for Veterinary Biologicals, it requires large number of hamsters. This is time-intensive and has large associated test variances. Due to increased awareness and social concern, use of animals is being restricted prompting scientists to device in vitro tests.
The Center for Veterinary Biologics in USA (USDA-APHIS) has developed an antigen capture ELISA for testing of leptospirosis vaccines containing Canicola, Grippotyphosa www.ijmm.org ) .
